growth/size/body
mortality/aging
• in response to stress due to cardiac dysfunction
|
• at 20 to 40 weeks, mice exhibit spontaneous mortality associated with severe left ventricular dysfunction unlike wild-type mice
• all mice die by day 300
|
cardiovascular system
• cardiac glycogen levels are higher than in wild-type mice
|
• the annulus fibrosis that insulates the atria from the ventricles is thinned, stretched, and disrupted unlike in wild-type mice
|
• distended myocytes are filled with glycogen unlike in wild-type mice
|
• at 8 to 10 weeks and 20 weeks
|
• left ventricular wall
|
• at 8 to 10 weeks and 20 weeks, fractional shortening is decreased and left ventricular end-diastolic diameter is increased compared to in wild-type mice
|
• mice exhibit spontaneous episodes of sinus bradycardia and various escape rhythms, including paroxysmal supraventricular tachycardia and atrial fibrillation unlike in wild-type mice
|
• at 8 to 10 weeks, mice exhibit decreased heart rate compared to in wild-type mice
• mice exhibit severe sinus bradycardia before death unlike wild-type mice
• however, heart rate at 20 weeks is normal
|
• mice exhibit preexcitation unlike in wild-type mice
|
• PR interval is shortened in 50% of mice
|
• in response to stress, mice exhibit syncope that led to death that is associated with severe and persistent sinus brachycardia unlike wild-type mice
|
• stress (induction of anesthesia and/or manipulation) results in syncope and leads to sudden death
|
homeostasis/metabolism
• cardiac glycogen levels are higher than in wild-type mice
|
• in response to stress, mice exhibit syncope that led to death that is associated with severe and persistent sinus brachycardia unlike wild-type mice
|
muscle
• cardiac glycogen levels are higher than in wild-type mice
|
• distended myocytes are filled with glycogen unlike in wild-type mice
|
• at 8 to 10 weeks and 20 weeks, fractional shortening is decreased and left ventricular end-diastolic diameter is increased compared to in wild-type mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
hypertrophic cardiomyopathy 6 | DOID:0110312 |
OMIM:600858 |
J:128648 |